Tricyclic antidepressants

35,209views

Tricyclic antidepressants

Watch later

Watch later

Attention deficit hyperactivity disorder (ADHD): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Selective serotonin reuptake inhibitors
Atypical antidepressants
Monoamine oxidase inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Atypical antipsychotics
Typical antipsychotics
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Psychomotor stimulants
Malaria: Clinical sciences
Sickle cell disease: Clinical sciences
Multiple myeloma: Clinical sciences
Zika virus
Dengue virus
Human T-lymphotropic virus
Trichuris trichiura (Whipworm)
Ancylostoma duodenale and Necator americanus
Babesia
Plasmodium species (Malaria)
Diphyllobothrium latum
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Antimalarials
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Dyslipidemia: Clinical sciences
Congestive heart failure: Clinical sciences
Infectious endocarditis: Clinical sciences
Cardiovascular disease screening: Clinical sciences
Deep vein thrombosis: Clinical sciences
Vasculitis: Pathology review
Adrenergic antagonists: Beta blockers
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Pheochromocytoma: Clinical sciences
Adrenal insufficiency: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Multiple endocrine neoplasia: Clinical sciences
Hyperparathyroidism: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Hypopituitarism: Pathology review
Pituitary tumors: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism medications
Alcohol-induced hepatitis: Clinical sciences
Cirrhosis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Acute pancreatitis: Clinical sciences
Pilonidal disease: Clinical sciences
Hemorrhoids: Clinical sciences
Perianal abscess and fistula: Clinical sciences
Anal fissure: Clinical sciences
Appendicitis: Clinical sciences
Diverticulitis: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Gastritis: Clinical sciences
Peptic ulcer disease: Clinical sciences
Stress ulcers: Clinical sciences
Celiac disease: Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Infectious gastroenteritis: Clinical sciences
Esophageal cancer: Clinical sciences
Anal cancer: Clinical sciences
Colorectal cancer: Clinical sciences
Gastric cancer: Clinical sciences
Femoral hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Inguinal hernias: Clinical sciences
Helicobacter pylori
Vibrio cholerae (Cholera)
Colorectal polyps and cancer: Pathology review
Acid reducing medications
Antidiarrheals
Hepatitis medications
Laxatives and cathartics
Well-patient care (adult): Clinical sciences
Well-patient care (GYN): Clinical sciences
Breast cancer screening: Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Cervical cancer screening: Clinical sciences
Colorectal cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Skin cancer screening: Clinical sciences
Anaphylaxis: Clinical sciences
Glucocorticoids
Non-corticosteroid immunosuppressants and immunotherapies
Hemochromatosis: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Reactive arthritis: Clinical sciences
Temporal arteritis: Clinical sciences
Systemic sclerosis (scleroderma): Clinical sciences
Infectious mononucleosis: Clinical sciences
Lyme disease: Clinical sciences
Burns: Clinical sciences
Hypothermia: Clinical sciences
Yellow fever virus
Seronegative and septic arthritis: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Environmental and chemical toxicities: Pathology review
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Azoles
Anthelmintic medications
Herpesvirus medications
Osteoporosis: Clinical sciences
Mechanical back pain: Clinical sciences
Gout: Clinical sciences
Calcium pyrophosphate deposition disease (pseudogout): Clinical sciences
Osteoarthritis: Clinical sciences
Inflammatory myopathies: Clinical sciences
Osteomyelitis: Clinical sciences
Septic arthritis: Clinical sciences
Compartment syndrome: Clinical sciences
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy clinical correlates: Knee
Anatomy clinical correlates: Leg and ankle
Antigout medications
Osteoporosis medications
Subarachnoid hemorrhage: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Multiple sclerosis: Clinical sciences
Myasthenia gravis: Clinical sciences
West Nile virus
Adult brain tumors: Pathology review
Local anesthetics
Migraine medications
Adrenergic antagonists: Alpha blockers
Medications for neurodegenerative diseases
Preconception care: Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Asthma in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Estrogens and antiestrogens
Progestins and antiprogestins
Lower urinary tract infection: Clinical sciences
Pyelonephritis: Clinical sciences
Approach to acute kidney injury: Clinical sciences
Chronic kidney disease: Clinical sciences
Nephrolithiasis: Clinical sciences
BK virus (Hemorrhagic cystitis)
Fibroadenoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Breast papilloma: Clinical sciences
Infertility: Clinical sciences
Uterine leiomyoma: Clinical sciences
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Testicular cancer: Clinical sciences
Benign breast conditions: Pathology review
Penile conditions: Pathology review
PDE5 inhibitors
Asthma: Clinical sciences
Sleep apnea: Clinical sciences
Coxiella burnetii (Q fever)
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Benign skin lesions: Clinical sciences
Chest X-ray interpretation: Clinical sciences

Transcript

Watch video only

Tricyclic antidepressants, or TCAs, are mainly used to treat major depressive disorder.

This disorder causes a persistent feeling of sadness and loss of interest in everyday activities.

Even though the exact cause of depression is still unknown, there's some evidence that suggests it’s related to low levels of neurotransmitters like serotonin, norepinephrine, and dopamine.

Tricyclic antidepressants work by increasing the levels of serotonin and norepinephrine to alleviate the symptoms of depression.

Alright, now within the brain, there are many different types of neurons, but we’re just going to focus on two: serotonergic neurons which produce serotonin, and noradrenergic neurons which produces norepinephrine.

Each of these neurons synthesizes and stores their neurotransmitters in small vesicles.

So, when an action potential reaches the presynaptic membrane, these vesicles fuse with the membrane, releasing neurotransmitters into the synaptic cleft.

Once released, serotonin or 5-HT binds to 5-HT2 receptors on the postsynaptic membrane, thereby increasing neural stimulation and regulating mood, feeding, and reproductive behavior.

On the other hand, norepinephrine binds to norepinephrine receptors on the postsynaptic membrane, boosting alertness.

As long as there’s a high enough concentration of neurotransmitters in the synaptic cleft, the postsynaptic neurons will continue to fire.

Now, serotonergic neurons, on their presynaptic membrane, have serotonin transporters or SERT, while noradrenergic neurons have norepinephrine transporters or NET.

These membrane proteins transport the serotonin and norepinephrine in the synaptic cleft back into presynaptic neurons.

This leads to decreased neurotransmitter concentration within the synaptic cleft, causing the postsynaptic neurons to stop firing.

So, in conditions such as major depressive disorder, tricyclic antidepressants can be used to increase the levels of serotonin and norepinephrine.

Tricyclic antidepressants are subdivided into 2 main groups: tertiary TCAs, which include amitriptyline, imipramine, and clomipramine; and secondary TCAs, which include desipramine and nortriptyline.

Tertiary TCAs are also known as non-selective tricyclic antidepressants and they inhibit both serotonin transporters and norepinephrine transporters, while secondary TCAs, which are also known as selective tricyclic antidepressants, inhibit only norepinephrine transporters.

This way, tricyclic antidepressants are increasing levels of serotonin and norepinephrine or just norepinephrine within the synaptic cleft, thus increasing the activity of postsynaptic neurons.

It's important to note that these medications are slow-acting because it takes time for serotonin and norepinephrine to accumulate within the synaptic cleft. Because of this, it usually takes 2-4 weeks before improvements can be seen.

Even though they’re very effective in the treatment of depression, tricyclic antidepressants are not considered as the first line therapy due to their severe side effects.

They’re typically reserved for when there is no response to other antidepressants, such as selective serotonin reuptake inhibitors, or SSRIs.

Other indications for TCAs include phobic disorders, chronic neuropathic pain, like peripheral neuropathy, and as migraine prophylaxis.

Now, for medication specific indications, clomipramine can be used in the treatment of obsessive-compulsive disorder, or OCD, while imipramine is used in the treatment of nocturnal enuresis, which is involuntary urination while asleep.

Besides serotonin and norepinephrine transporters, TCAs also block histamine H1 receptors, causing sedation; alpha 1 receptors, causing orthostatic hypotension; and muscarinic receptors, causing atropine-like side effects.

Atropine-like side effects occur more commonly with tertiary TCAs and they include dry mouth, tachycardia, urinary retention, confusion, and hallucinations.

TCAs can also cause serotonin syndrome, which is a life-threatening condition caused by serotonin accumulation and over stimulation of the nervous system.

Key Takeaways

Tricyclic antidepressants (TCAs) are a class of medications used to treat depression, anxiety disorders, migraine, and chronic pain. They are named for their chemical structure, which includes three rings of atoms.

TCAs work by preventing serotonin and norepinephrine reuptake from the synaptic cleft, thus enhancing the effect of both neurotransmitters on postsynaptic neurons. Some common TCAs include amitriptyline, imipramine, and nortriptyline.

Common side effects include dry mouth, blurred vision, constipation, dizziness, and drowsiness. TCAs can also cause more serious side effects, such as heart rhythm disturbances, seizures, and an increased risk of suicide, particularly in younger individuals.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Mechanism of action of antidepressant medications" J Clin Psychiatry (1990)
  5. "Tricyclic antidepressant pharmacology and therapeutic drug interactions updated" British Journal of Pharmacology (2007)
  6. "Tricyclic antidepressant overdose: a review" Emerg Med J (2001)
  7. "Neuroleptic malignant syndrome and serotonin syndrome" Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II (2018)